Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Inhibition of Wnt-2 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells.

Shi Y, He B, Kuchenbecker KM, You L, Xu Z, Mikami I, Yagui-Beltran A, Clement G, Lin YC, Okamoto J, Bravo DT, Jablons DM.

Int J Cancer. 2007 Sep 15;121(6):1175-81.

PMID:
17534895
[PubMed - indexed for MEDLINE]
2.

Targeting the most upstream site of Wnt signaling pathway provides a strategic advantage for therapy in colorectal cancer.

Qi J, Zhu YQ.

Curr Drug Targets. 2008 Jul;9(7):548-57. Review.

PMID:
18673240
[PubMed - indexed for MEDLINE]
3.

Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.

Pendás-Franco N, Aguilera O, Pereira F, González-Sancho JM, Muñoz A.

Anticancer Res. 2008 Sep-Oct;28(5A):2613-23. Review.

PMID:
19035286
[PubMed - indexed for MEDLINE]
Free Article
4.

Colorectal cancer and genetic alterations in the Wnt pathway.

Segditsas S, Tomlinson I.

Oncogene. 2006 Dec 4;25(57):7531-7. Review.

PMID:
17143297
[PubMed - indexed for MEDLINE]
5.

Wnt-1 signal as a potential cancer therapeutic target.

You L, Kim J, He B, Xu Z, McCormick F, Jablons DM.

Drug News Perspect. 2006 Jan-Feb;19(1):27-31. Review.

PMID:
16550254
[PubMed - indexed for MEDLINE]
6.

Functions of galectin-3 and its role in fibrotic diseases.

Li LC, Li J, Gao J.

J Pharmacol Exp Ther. 2014 Nov;351(2):336-43. doi: 10.1124/jpet.114.218370. Epub 2014 Sep 5. Review.

PMID:
25194021
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk